Answers are grounded in this paper and cite their sources.
Background Central drop foot, arising in conditions such as stroke and multiple sclerosis, results in an unstable gait pattern, altered gait mechanisms, and increased risk of falls. Semi-implantable functional electrical stimulation (siFES) of the peroneal nerve provides an effective therapy, as indexed by walking speed. Reports indicate that it retains its efficacy up to a year after implantation. However, whether the effects persist over an extended period beyond this time was unknown. Methods We evaluated the outcome over a mean of 8.5 years post-implantation in a patient cohort ( N = 45) for whom improvements were previously reported at one year, assessing maximum and comfortable gait velocity and quality of life using the Short Form 36 questionnaire. Results At this extended time point, gait velocity was faster, both at maximum and at comfortable pace, with stimulation on than off (p’s < 0.001). Main effects of Stimulation (on, off) and Time (one day, three months, one-year, extended period) were observed for maximum gait velocity ( p < 0.001; p = 0.012). Walking was faster with stimulation on, with no change in response to stimulation over time. The effect of Stimulation persisted when correcting for severity of paresis and age. For comfortable gait velocity, only the effect of Stimulation was significant ( p < 0.001), and a significant interaction was seen between Stimulation and Age ( p = 0.002). Although larger stimulation effects were observed in younger patients, the magnitude of the stimulation-induced speed difference did not show a significant linear correlation with age. The initial quality of life score improvement was followed by a gradual decline, with a remaining trend towards better quality of life at the extended period than initially ( p = 0.13), which may reflect age-related challenges and developing comorbid conditions. Conclusions These findings suggest that siFES for central drop foot continues to provide effective treatment nearly a decade after implantation, rendering it a useful life-long treatment.
No takes yet. Share an insight, caveat, or question.
Sweeney‐Reed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: